Exagen Inc. (NASDAQ:XGN) Q1 2026 Earnings Call Transcript
Exagen Inc. (NASDAQ:XGN) Q1 2026 Earnings Call Transcript May 11, 2026Exagen Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.
Exagen Inc. (XGN)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Wexford Capital Charles Davidson | 792,855 | $3,686,776 | 0.47% | |
| 2. | FourWorld Capital Management John Addis | 596,528 | $2,773,855 | +36% | 2.52% |
| 3. | First Eagle Investment Management Jean-Marie Eveillard | 306,965 | $1,427,387 | +146% | 0% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 306,703 | $1,426,169 | +1024% | 0% |
| 5. | GLG Partners Noam Gottesman | 167,292 | $777,908 | +29% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.98 | 22,298 | $66,448.04 | 274,492 | 2024-11-15 | Filing | |
| $2.81 | 24,305 | $68,297.05 | 689,799 | 2024-11-14 | Filing | |
| $1.92 | 40,401 | $77,569.92 | 40,401 | 2024-05-16 | Filing | |
| $3.11 | 167 | $519.45 | 1,515,839 | 2023-06-15 | Filing | |
| $2.68 | 90,000 | $241,200.00 | 440,000 | 2022-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.22 | 20,614 | $148,781.55 | 323,339 | 2026-09-01 | Filing | |
| $3.62 | 15,698 | $56,826.76 | 687,299 | 2026-03-03 | Filing | |
| $3.61 | 11,430 | $41,262.30 | 702,997 | 2026-02-24 | Filing | |
| $3.61 | 1,584 | $5,718.24 | 267,442 | 2026-02-24 | Filing | |
| $11.82 | 31,787 | $375,598.37 | 714,427 | 2025-10-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 675,000 | $3,138,750 | 2.41% | |
| 2. | 612,832 | $2,849,669 | 0% | |
| 3. | 514,761 | $2,393,639 | 0.02% | |
| 4. | 485,048 | $2,255,473 | 0.04% | |
| 5. | 475,944 | $2,213,140 | 0.98% |
News See All
10 Stocks Under $5 That Will Explode
In this piece, we will discuss the 10 Stocks Under $5 That Will Explode.
Exagen Inc. (NASDAQ:XGN) Q3 2025 Earnings Call Transcript
Exagen Inc. (NASDAQ:XGN) Q3 2025 Earnings Call Transcript November 4, 2025Exagen Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $-0.13.
Exagen Inc. (NASDAQ:XGN) Q2 2025 Earnings Call Transcript
Exagen Inc. (NASDAQ:XGN) Q2 2025 Earnings Call Transcript July 29, 2025Exagen Inc. reports earnings inline with expectations. Reported EPS is $-0.18 EPS, expectations were $-0.18.
Exagen Inc. (XGN): A Bull Case Theory
This stock is one of several featured in our latest research.
10 Promising SmallCap Stocks Under $1 Billion Market Cap
In this article, we look at 10 promising SmallCap stocks under $1 billion in market capitalization.
Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript
Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Greetings, and welcome to Exagen Inc. First Quarter 2025 Earnings Conference Call.
Exagen Inc. (NASDAQ:XGN) Q4 2024 Earnings Call Transcript
Exagen Inc. (NASDAQ:XGN) Q4 2024 Earnings Call Transcript March 11, 2025Exagen Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.27.
Exagen Inc. (NASDAQ:XGN) Q3 2024 Earnings Call Transcript
Exagen Inc. (NASDAQ:XGN) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Greetings. Welcome to the Exagen Inc. Third Quarter 2024 Earnings Call.
Exagen Inc. (NASDAQ:XGN) Q2 2024 Earnings Call Transcript
Exagen Inc. (NASDAQ:XGN) Q2 2024 Earnings Call Transcript August 5, 2024Exagen Inc. beats earnings expectations. Reported EPS is $-0.16316, expectations were $-0.36. Operator: Greetings.
Hedge Fund Resource Center